quinoxalines has been researched along with Uterine Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burgert, M; Cadacio, C; Everitt, JI; Frazier, KS; Gold, LI; Laping, NJ; Portis, MJ; Walker, CL | 1 |
| Alwani, DW; Masters, BR; Noble, AC; Popp, FD; Schuyler, P | 1 |
2 other study(ies) available for quinoxalines and Uterine Neoplasms
| Article | Year |
|---|---|
Tumor-specific efficacy of transforming growth factor-beta RI inhibition in Eker rats.
Topics: Activin Receptors, Type I; Animals; Apoptosis; Carcinoma, Renal Cell; Female; Imidazoles; Kidney Neoplasms; Leiomyoma; Mitosis; Protein Serine-Threonine Kinases; Quinoxalines; Rats; Rats, Inbred Strains; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Signal Transduction; Transforming Growth Factor beta; Uterine Neoplasms | 2007 |
Synthesis of potential antineoplastic agents. XV. Some l,4-bisamides of 1,2,3,4-tetrahydroquinoxaline.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Chemistry, Organic; Female; Leiomyosarcoma; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Neoplasms, Experimental; Organic Chemistry Phenomena; Quinolines; Quinoxalines; Sarcoma 180; Sarcoma, Experimental; Sarcoma, Yoshida; Uterine Neoplasms | 1966 |